As a compounded preparation, it has not undergone FDA review for safety, effectiveness, or manufacturing quality as a finished product, and it should not be treated as equivalent to Ozempic or Wegovy - those are the FDA-approved, brand-name semaglutide products, manufactured and reviewed separately by Novo Nordisk
Early studies show they can be highly effective for weight loss in this group, leading to improved cycle regularity and ovulation
The active ingredient, guaifenesin, is an expectorant that works by thinning and loosening mucus in the airways, making it easier to cough up and clear congestion caused by colds, infections, or allergies
The liquid solution is far more fragile, and a new set of rules applies
This warrants further investigation in future prospective patient cohorts
Image source: Therapeutic Drug Database: